Suppr超能文献

离体工作大鼠心脏中的血管内ATP与冠状动脉舒张

Intravascular ATP and coronary vasodilation in the isolated working rat heart.

作者信息

Korchazhkina O, Wright G, Exley C

机构信息

Birchall Centre for Inorganic Chemistry and Materials Science, Department of Chemistry, Keele University, Staffordshire.

出版信息

Br J Pharmacol. 1999 Jun;127(3):701-8. doi: 10.1038/sj.bjp.0702610.

Abstract
  1. Adenosine-5'-triphosphate (ATP) is a potent coronary vasodilator. Because of the efficient hydrolysis of ATP, adenosine-5'-diphosphate (ADP) and adenosine-5'-monophosphate (AMP) by ectonucleotidases located in the coronary endothelium ATP-induced vasodilation may be mediated via both P1 (AMP and adenosine) and P2Y (ATP and ADP) receptors. We have used the change in total coronary resistance (TCR) induced by intravascular ATP in the isolated working rat heart to determine both the component of the vasodilation mediated via P2Y receptors and the identity of the subclass of receptor involved. 2. The dose response for ATP revealed a half maximal effect at an apparent ATP concentration of 0.08 +/- 0.009 microM. The response was saturated at apparent ATP concentrations greater than 0.23 microM. Contrary to much of the current literature, the perfusion of a 0.25 microM concentration of adenosine resulted in the identical response to an equimolar concentration of ATP suggesting a significant role for adenosine in coronary vasodilation. 3. The non-selective P1 receptor antagonist 8-(p-Sulfophenyl)theophylline (8-SPT) was used to show that the response to ATP was mediated via both P1 and P2Y receptors. Whilst 8-SPT abolished the effect of adenosine it reduced the effect of ATP by only 50%. Thus, at a saturating concentration of ATP, P1 and P2Y receptors were shown to contribute equally to the observed vasodilation. 4. Uridine-5'-triphosphate (UTP), ADP and adenosine-5'-O-thiotriphosphate (ATP gamma S) were used to characterize the component of coronary vasodilation that was mediated via P2Y receptors. UTP at 0.25 microM was ineffective and did not induce vasodilation. Perfusion with 0.25 microM ADP resulted in a vasodilation that was identical to 0.25 microM ATP. In the absence of 8-SPT the perfusion of 0.25 microM ATP gamma S produced a vasodilation that was significantly (P < 0.05) less than ATP. However, the vasodilation due to ATP gamma S, like that of adenosine, but unlike that of both ATP and ADP, was abolished in the presence of 8-SPT. The ability of ADP to induce vasodilation combined with both the lack of response to UTP and the ability of 8-SPT to abolish the vasodilation induced by ATP gamma S suggested very strongly that the component of ATP-induced coronary vasodilation in the isolated working rat heart that was mediated via P2Y receptors was achieved by the action of ADP (and not ATP) at P2Y1 receptors. 5. These results suggest that the vasodilatory action of intravascular ATP in the coronary circulation should be attributed to the dual and equal activities of adenosine and ADP acting at P1 and P2Y1 receptors respectively.
摘要
  1. 腺苷 - 5'-三磷酸(ATP)是一种强效的冠状动脉血管扩张剂。由于位于冠状动脉内皮的外核苷酸酶能高效水解ATP,生成腺苷 - 5'-二磷酸(ADP)和腺苷 - 5'-单磷酸(AMP),ATP诱导的血管舒张可能通过P1(AMP和腺苷)和P2Y(ATP和ADP)受体介导。我们利用离体工作大鼠心脏中血管内ATP诱导的总冠状动脉阻力(TCR)变化,来确定通过P2Y受体介导的血管舒张成分以及所涉及的受体亚类。2. ATP的剂量反应在表观ATP浓度为0.08±0.009微摩尔时显示出半数最大效应。在表观ATP浓度大于0.23微摩尔时反应达到饱和。与当前许多文献相反,灌注0.25微摩尔浓度的腺苷导致的反应与等摩尔浓度的ATP相同,这表明腺苷在冠状动脉血管舒张中起重要作用。3. 非选择性P1受体拮抗剂8 - (对 - 磺基苯基)茶碱(8 - SPT)用于表明对ATP的反应是通过P1和P2Y受体介导的。虽然8 - SPT消除了腺苷的作用,但它仅使ATP的作用降低了50%。因此,在ATP饱和浓度下,P1和P2Y受体对观察到的血管舒张作用相同。4. 尿苷 - 5'-三磷酸(UTP)、ADP和腺苷 - 5'-O - 硫代三磷酸(ATPγS)用于表征通过P2Y受体介导的冠状动脉血管舒张成分。0.25微摩尔的UTP无效,未诱导血管舒张。灌注0.25微摩尔的ADP导致的血管舒张与0.25微摩尔的ATP相同。在没有8 - SPT的情况下,灌注0.25微摩尔的ATPγS产生的血管舒张明显(P < 0.05)小于ATP。然而,与腺苷一样,但与ATP和ADP不同,ATPγS引起的血管舒张在存在8 - SPT时被消除。ADP诱导血管舒张的能力,以及对UTP缺乏反应和8 - SPT消除ATPγS诱导的血管舒张的能力,非常强烈地表明,在离体工作大鼠心脏中,通过P2Y受体介导的ATP诱导的冠状动脉血管舒张成分是由ADP(而非ATP)作用于P2Y1受体实现的。5. 这些结果表明,冠状动脉循环中血管内ATP的血管舒张作用应归因于腺苷和ADP分别作用于P1和P2Y1受体的双重且相同的活性。

相似文献

8
Nucleotide coronary vasodilation in guinea pig hearts.豚鼠心脏中的核苷酸冠状动脉舒张
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1040-7. doi: 10.1152/ajpheart.00981.2002. Epub 2003 May 22.
9
Purinoceptors in the rat heart.大鼠心脏中的嘌呤受体。
Br J Pharmacol. 1987 Jan;90(1):219-27. doi: 10.1111/j.1476-5381.1987.tb16843.x.

引用本文的文献

3
Cardiac purinergic signalling in health and disease.健康与疾病中的心脏嘌呤能信号传导
Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20.
6
Functional contribution of P2Y1 receptors to the control of coronary blood flow.P2Y1 受体在冠状动脉血流控制中的功能贡献。
J Appl Physiol (1985). 2011 Dec;111(6):1744-50. doi: 10.1152/japplphysiol.00946.2011. Epub 2011 Sep 22.
8
Nucleotide coronary vasodilation in guinea pig hearts.豚鼠心脏中的核苷酸冠状动脉舒张
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1040-7. doi: 10.1152/ajpheart.00981.2002. Epub 2003 May 22.

本文引用的文献

3
Agonist-induced internalization of the P2Y2 receptor.激动剂诱导的P2Y2受体内化
Mol Pharmacol. 1998 Sep;54(3):485-94. doi: 10.1124/mol.54.3.485.
4
Action of Al-ATP on the isolated working rat heart.铝-三磷酸腺苷对离体大鼠工作心脏的作用。
J Inorg Biochem. 1998 Feb 15;69(3):153-8. doi: 10.1016/s0162-0134(97)10012-5.
7
Towards a revised nomenclature for P1 and P2 receptors.迈向P1和P2受体的修订命名法。
Trends Pharmacol Sci. 1997 Mar;18(3):79-82. doi: 10.1016/s0165-6147(96)01038-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验